441011003: Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Propionic acid and/or propionic acid derivative-containing product\Product containing meglitinide (medicinal product)\Product containing repaglinide (medicinal product)\Repaglinide-containing product in oral dose form\Metformin- and repaglinide-containing product in oral dose form\Product containing only metformin and repaglinide in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Propionic acid and/or propionic acid derivative-containing product\Product containing meglitinide (medicinal product)\Product containing repaglinide (medicinal product)\Product containing metformin and repaglinide (medicinal product)\Metformin and repaglinide only product\Product containing only metformin and repaglinide in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Propionic acid and/or propionic acid derivative-containing product\Product containing meglitinide (medicinal product)\Product containing repaglinide (medicinal product)\Product containing metformin and repaglinide (medicinal product)\Metformin- and repaglinide-containing product in oral dose form\Product containing only metformin and repaglinide in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing biguanide (product)\Product containing metformin (medicinal product)\Metformin-containing product in oral dose form\Metformin- and repaglinide-containing product in oral dose form\Product containing only metformin and repaglinide in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing biguanide (product)\Product containing metformin (medicinal product)\Product containing metformin and repaglinide (medicinal product)\Metformin and repaglinide only product\Product containing only metformin and repaglinide in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing biguanide (product)\Product containing metformin (medicinal product)\Product containing metformin and repaglinide (medicinal product)\Metformin- and repaglinide-containing product in oral dose form\Product containing only metformin and repaglinide in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)

\Product manufactured as oral dose form (product)\Repaglinide-containing product in oral dose form\Metformin- and repaglinide-containing product in oral dose form\Product containing only metformin and repaglinide in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)
\Product manufactured as oral dose form (product)\Metformin-containing product in oral dose form\Metformin- and repaglinide-containing product in oral dose form\Product containing only metformin and repaglinide in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3680571014 Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3680572019 Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4676741000052111 metforminhydroklorid 500 milligram och repaglinid 2 milligram, oral tablett sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing metformin and repaglinide (medicinal product)	false	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product manufactured as oral dose form (product)	false	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has active ingredient	Repaglinide (substance)	false	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has active ingredient	Metformin hydrochloride	false	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has manufactured dose form	Oral tablet	true	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Metformin-containing product in oral dose form	false	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Repaglinide (substance)	false	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	har täljarvärde som visar styrka	två	false	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	har nämnarvärde som visar styrka	ett	false	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Metformin hydrochloride	false	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	har täljarvärde som visar styrka	500	false	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator unit	mg	true	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	har nämnarvärde som visar styrka	ett	false	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit (attribute)	Tablet (unit of presentation)	true	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has active ingredient	Metformin hydrochloride	false	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Metformin hydrochloride	true	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	har täljarvärde som visar styrka	500	false	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has active ingredient	Repaglinide (substance)	false	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	Repaglinide (substance)	true	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	har täljarvärde som visar styrka	två	false	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Repaglinide (substance)	false	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Metformin hydrochloride	false	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Metformin- and repaglinide-containing product in oral dose form	false	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	räkning av bas i aktiv ingrediens	två	false	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing only metformin and repaglinide in oral dose form (medicinal product form)	true	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Repaglinide (substance)	true	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	Metformin hydrochloride	true	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing biguanide (product)	false	Inferred relationship	Some
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Repaglinide-containing product in oral dose form	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3680571014	Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3680572019	Metformin hydrochloride 500 mg and repaglinide 2 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4676741000052111	metforminhydroklorid 500 milligram och repaglinid 2 milligram, oral tablett	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)